Back
Belite Bio, Inc. Stock Predictions
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
54
BLTE
Belite Bio, Inc.
Last Price:
$154.94
Seasonality Move:
-4.96%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available atBelite Bio, Inc. Stock Forecast
-
Over the next 52 weeks, Belite Bio, Inc. has on average historically risen by 84.4% based on the past 3 years of stock performance.
-
Belite Bio, Inc. has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
-
Is Belite Bio, Inc. Stock Undervalued?The current Belite Bio, Inc. [BLTE] share price is $155.11. The Score for BLTE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BLTE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Belite Bio, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Belite Bio, Inc. has on average historically risen by 84.4% based on the past 3 years of stock performance.
Belite Bio, Inc. Stock Rating
Buy
54
Belite Bio, Inc. (BLTE)
is a Buy
Is Belite Bio, Inc. overpriced?
-
Belite Bio, Inc. has risen higher in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Belite Bio, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
belitebio.com
52-Week Data
52-Week High:
170.25
52-Week Low:
49.00
Prediction Charts
Market Cap:
5.8B
Price in USD:
155.11
Volume:
159.5K
Beta:
-1.33
Technical Analysis
SMA50:
141.33
SMA100:
109.23
SMA200:
85.70
52-Wk Change:
192.44%
Stock Predictions
-
Is Belite Bio, Inc. stock public?Yes, Belite Bio, Inc. is a publicly traded company.
-
What is the Belite Bio, Inc. stock quote today?The Belite Bio, Inc. stock price is 155.11 USD today.
-
How to buy Belite Bio, Inc. stock online?You can buy Belite Bio, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-26 | 154.51 | 154.93 | 155.48 | 153.62 |
| Dec-29 | 154.93 | 165.29 | 169.75 | 151.50 |
| Dec-30 | 164.35 | 160.82 | 165.29 | 156.71 |
| Dec-31 | 159.80 | 159.96 | 161.80 | 158.21 |
| Jan-5 | 159.17 | 159.42 | 160.50 | 153.56 |
| Jan-6 | 162.20 | 160.18 | 162.49 | 157.35 |
| Jan-7 | 162.41 | 164.20 | 165.25 | 158.00 |
| Jan-8 | 164.99 | 164.01 | 170.25 | 163.64 |
| Jan-9 | 164.05 | 158.36 | 166.00 | 155.49 |
| Jan-12 | 159.61 | 154.79 | 159.95 | 146.06 |
| Jan-13 | 154.50 | 156.95 | 158.00 | 152.99 |
| Jan-14 | 157.00 | 153.68 | 157.50 | 149.50 |
| Jan-15 | 153.90 | 149.61 | 155.50 | 148.56 |
| Jan-16 | 151.00 | 155.11 | 157.48 | 148.10 |
Belite Bio, Inc. Earnings
Belite Bio, Inc. Earnings Report: Per Share Belite Bio, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Belite Bio, Inc. Forecast Revenue Growth
Belite Bio, Inc. Stock Analysis: Historical quarterly revenues per share for Belite Bio, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.29 per share, and an increase next year of $0.33 per share.
* Belite Bio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.